Grant
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
- Organisation
- European Commission (Funding & Tenders)
- Where
- Worldwide
- Mode
- On site
- Funding
- See details
- For
- Professionals, PhD & postdoctoral
- Deadline
- 16 September 2027 (327 days left)
- Source
- Call for proposals from the EU Funding & Tenders Portal (© European Union)
About
Expected Outcome:
Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:
Patients with rare or very rare cancers or cancer subtypes have access to tailored, promising biomarker-guided medicines or multi-modal treatment interventions via participation in subsequent clinical trials or national or regional compassionate use programmes by health authorities;
Researchers, physicians, innovators [1] , startup, spin-off and spin-out companies, SMEs, charities or foundations and other professionals from
Forthcoming call: opens 2027-02-10.
Eligibility, full details and the official apply link
Members see the complete record, the direct link to apply, a personal match score and deadline reminders.
Unlock it free See plans